{"title": "PDF", "author": "PDF", "url": "https://www.maine.gov/dhhs/mecdc/infectious-disease/immunization/documents/COVID-Vaccines_ME-DHHS_Core-Set_02-23-2021.pdf", "hostname": "PDF", "description": "PDF", "sitename": "PDF", "date": "PDF", "cleaned_text": "Maine DHHS COVID-19 Vaccines Information for Clinicians Lisa M. Letourneau MD, MPH, ME DHHS Peggy Pennoyer MD Stephen Sears MD, MPH, ME CDC February 23, 2021 Welcome 2Introductions Session goals & format CME available (0.5 AMA PRA Cat 1 Credit/session) If CME desired, pls email your name & session attended to COVIDCME.DHHS@maine.gov Future sessions Current contextThe planners and faculty for this activity do not have any relevant financial relationships to disclose with any Commercial Interests and do not have any conflicts of interest to resolve 3DisclosuresCOVID- 19 Vaccines - Info for Clinicians 4Context Science of vaccines Assessing & managing allergy issues Safety monitoring New vaccines Promoting vaccine equity Vaccine hesitancy Reporting & tracking adverse eventsPrevaccination Checklist - US CDC https://www.cdc.g ov/vaccines/covid - 19/downloads/pre - vaccination - screening -form.pdfMaineHealth no special cold -storage requirmnts S ingle dose 72% effective in US, 66% effective across all sites at preventing moderate to severe COVID -19 at 28D post-vaccination 8 5% effective across sites in preventing severe disease 1 00% efficacy preventing hospitalization & death S ingle dose & no cold storage requirements allow for wider distribution across settings Mo re rapid vaccination of large groups offers communities important protection An ticipate FDA review Feb 26 https://www.cdc.gov/mmwr/volumes/70/wr/pdfs/12 Safety MonitoringME DHHS Health 3rdWed/mo , 7:30 monthly series: https://zoom.us/meeting/register/tJcsfuGvpj0jGdaRiW 5Y15qnYa2AMVriHgaI , OR L og on at the the webinar with 14 Available in 10 languagesState COVID Vaccine Updates Maine residency requirement ME CDC HAN -Notifiable Conditions update - ongoing monitoring for variants ME DHHS \"Full Use Policy \" Opport unities for Community Collaborative proposals A dherence to State of Maine priority Phases W algreens & Walmart vaccination sites 15Phase 1a Health Care Personnel Residents & staff of long -term care facilities Public safety State COVID response critical personnelPhase 1b Older adults 70 yo1 65-69 yo2 Persons with high- risk medical conditions Front line essential workers Phase 1c Other essential workers Maine Phases for Vaccine Distribution* *Updates posted to Gov Mills COVID Vaccine website: www.maine.gov/covid19/vaccines 1 70+yo: Currently being vaccinated 2 65-69yo: Anticipate starting vaccination early March NOTE: Facilities booking appts listed at: www.maine.gov/covid19/vaccines/vaccination -sitesPhase 2 Persons aged 16 -64 & not already eligible17 www.maine.gov/covid19/vaccinesGov Mills Info COVID Vaccine 18 www.maine.gov/covid19/vaccinesGov Mills Info COVID Vaccine 19 Gov Mills Info COVID Vaccine www.maine.gov/covid19/vaccines20 ME CDC COVID -19 Vaccine Resources (www.maine.gov/dhhs/mecdc/infectious -disease/immunization/covid -19-providers/index.shtml ME Resources Vaccine Email: C19vaccine.MECDC@maine.govL isa Letourneau MD, MPH Senior Advisor DHHS MD, MPH Consulting Epidemiologist, Maine CDC Stephen.sears@maine.gov C: 207-458-2351 21 Maine Department of "}